[177Lu] Lu-PSMA-617 treatment for metastatic castration-resistant prostate cancer (mCRPC) with cerebral and cerebellar metastases.
Saved in:
| Title: | [177Lu] Lu-PSMA-617 treatment for metastatic castration-resistant prostate cancer (mCRPC) with cerebral and cerebellar metastases. |
|---|---|
| Authors: | Belge Bilgin, Gokce1 (AUTHOR) belgebilgin.gokce@mayo.edu, Bilgin, Cem1 (AUTHOR), Burkett, Brian J.1 (AUTHOR), Thorpe, Matthew P.1 (AUTHOR), Packard, Ann T.1 (AUTHOR), Fidanli, Fatma1 (AUTHOR), Childs, Daniel S.2 (AUTHOR), Muniz, Miguel2 (AUTHOR), Orme, Jacob J.2 (AUTHOR), Quevedo, J. Fernando2 (AUTHOR), Kizilbash, Sani H.2 (AUTHOR), Kwon, Eugene D.3,4 (AUTHOR), Johnson, Geoffrey B.1,3 (AUTHOR), Johnson, Derek R.1 (AUTHOR), Sartor, Oliver1,2,3 (AUTHOR), Kendi, Ayse Tuba1 (AUTHOR) |
| Source: | European Journal of Nuclear Medicine & Molecular Imaging. Jan2026, Vol. 53 Issue 2, p824-832. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
